PriceSensitive

Emerging AI marketing company seals Fortune 50 deal

Market News, Technology
CSE:BPAI
24 February 2026 10:28 (EST)

Artistic rendering of AI marketing tool. (Source: Adobe Stock)

BrandPilot AI (CSE:BPAI), a performance marketing technology company, landed five new deals for enterprise trials and audit engagements, including with a US-based Fortune 50 healthcare benefits provider serving more than 115 million people. Here’s a breakdown:

The news follows strong recent client results, including CPC reductions of up to 90 per cent and trial-to-contract conversion rates of more than 80 per cent, which is accelerating enterprise adoption.

BrandPilot AI’s client pipeline currently represents millions of dollars in monthly digital advertising spend, positioning leadership to parlay AdAi’s measurable efficiency improvements into contracts and recurring revenue.

Management commentary

“AdAi continues to deliver strong outcomes for our clients, recovering significant budget for further growth, while in some cases driving CPC reductions of up to 90 per cent,” Brandon Mina, chief executive officer of BrandPilot AI, said in Tuesday’s news release. “As a result, we are seeing accelerating momentum across the pipeline, with a growing number of enterprise clients entering trials and a high percentage converting to commercial engagements. This reflects increasing demand for independent technologies that help advertisers improve efficiency and regain control over automated advertising environments.”

About BrandPilot AI

BrandPilot AI  is a performance marketing technology company based in Toronto, Canada. The company focuses on streamlining and optimizing digital advertising for global enterprise brands.

BrandPilot AI stock (CSE:BPAI) is unchanged trading at C$0.015 as of 9:49 am ET. The stock has given back 25 per cent year-over-year and more than 60 per cent since inception in July 2024.

Join the discussion: Find out what investors are saying about this AI marketing technology stock on the BrandPilot AI Inc. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.

For full disclaimer information, please click here.


Related News